American International Group, Inc. Ngm Biopharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.17 - $1.92 $215 - $353	-184 Reduced 0.85%	21,480 $34,000
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.31 $52 - $113	-87 Reduced 0.4%	21,664 $18,000
Q3 2023 Nov 13, 2023	BUY	$1.05 - $3.37 $811 - $2,605	773 Added 3.68%	21,751 $23,000
Q2 2023 Aug 04, 2023	BUY	$2.44 - $4.53 $3,577 - $6,640	1,466 Added 7.51%	20,978 $54,000
Q1 2023 May 12, 2023	BUY	$3.72 - $5.4 $1,443 - $2,095	388 Added 2.03%	19,512 $79,000
Q4 2022 Feb 10, 2023	BUY	$3.41 - $12.93 $852 - $3,232	250 Added 1.32%	19,124 $96,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $6,584 - $9,241	523 Added 2.85%	18,874 $247,000
Q2 2022 Aug 12, 2022	BUY	$10.58 - $17.5 $28,650 - $47,390	2,708 Added 17.31%	18,351 $235,000
Q1 2022 May 13, 2022	SELL	$13.81 - $18.6 $15,204 - $20,478	-1,101 Reduced 6.58%	15,643 $239,000
Q4 2021 Feb 11, 2022	SELL	$17.26 - $22.02 $8,647 - $11,032	-501 Reduced 2.91%	16,744 $297,000
Q3 2021 Nov 12, 2021	SELL	$20.15 - $26.19 $8,261 - $10,737	-410 Reduced 2.32%	17,245 $362,000
Q2 2021 Aug 13, 2021	BUY	$15.06 - $30.03 $40,059 - $79,879	2,660 Added 17.74%	17,655 $348,000
Q1 2021 May 07, 2021	BUY	$24.99 - $31.93 $28,338 - $36,208	1,134 Added 8.18%	14,995 $436,000
Q4 2020 Feb 12, 2021	SELL	$16.21 - $31.44 $6,451 - $12,513	-398 Reduced 2.79%	13,861 $420,000
Q3 2020 Nov 04, 2020	SELL	$15.59 - $19.97 $1,527 - $1,957	-98 Reduced 0.68%	14,259 $227,000
Q2 2020 Aug 12, 2020	SELL	$11.97 - $23.47 $1,173 - $2,300	-98 Reduced 0.68%	14,357 $283,000
Q1 2020 May 04, 2020	SELL	$10.0 - $19.51 $8,340 - $16,271	-834 Reduced 5.45%	14,455 $178,000
Q4 2019 Feb 05, 2020	BUY	$9.97 - $20.28 $109,410 - $222,552	10,974 Added 254.32%	15,289 $283,000
Q3 2019 Nov 08, 2019	BUY	$13.09 - $18.19 $497 - $691	38 Added 0.89%	4,315 $60,000
Q2 2019 Aug 13, 2019	BUY	$12.56 - $16.6 $53,719 - $70,998	4,277 New	4,277 $63,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account